Electronics Guide

Available Energy Sources and Power Budgets

The body offers thermal, mechanical, and chemical energy. The thermal gradient between core and skin is modest, typically only a few degrees Celsius, which limits thermoelectric output to the microwatt to low-milliwatt range per square centimeter. Mechanical sources are more energetic: the beating heart performs on the order of one joule of mechanical work per contraction, and bulk body motion during walking dissipates watts at the joints. Chemical energy is the largest reservoir of all, since the glucose and oxygen continuously supplied by the bloodstream represent a power density far exceeding what any practical implant would consume. The engineering challenge is rarely the absence of energy but rather the difficulty of extracting it efficiently within a small, biocompatible, and safe device.

Realistic implant power budgets help frame the problem. A modern cardiac pacemaker draws on the order of ten microwatts on average, though the figure varies with pacing rate, telemetry, and rate-responsive features. Neural recording and stimulation systems range from tens of microwatts to several milliwatts depending on channel count and stimulation intensity. Many wireless biosensors, transmitting intermittently, average well below one milliwatt. These figures are within reach of several harvesting mechanisms, which is precisely why in-vivo harvesting has moved from speculation toward demonstrated prototypes and, in the case of transcutaneous power, established clinical practice.

Constraints Imposed by Living Tissue

Living tissue imposes constraints that have no analog in conventional electronics. Temperature rise must be tightly limited, because sustained heating of only a few degrees can damage cells; a widely cited guideline holds that implant surface temperature rise should remain below about two degrees Celsius. Electrical safety requires that fault currents and field exposures stay well within limits that prevent tissue stimulation or heating. Mechanical compliance matters because rigid devices can erode soft tissue and provoke chronic inflammation. Every material in contact with tissue must be biocompatible and stable against the saline, enzyme-rich, and immunologically active fluids of the body.

Space is severely limited as well. An implant must be small enough to place without disrupting organ function, which constrains the volume available for transducers, energy storage, and electronics alike. These combined limits mean that an implantable harvester is always a compromise among power output, size, safety, and biological compatibility, and that a design optimal for a benchtop demonstration may be entirely unsuitable for chronic use.

Thermoelectric Conversion in the Body

Thermoelectric generators use the Seebeck effect to convert a temperature difference directly into voltage with no moving parts. In an implanted or wearable configuration, the hot side couples to deep tissue or the body core while the cold side rejects heat toward the skin surface and the surrounding air. The achievable temperature difference across a thin device is small, often a fraction of a degree to a few degrees, so the output voltage from a single thermocouple is tiny and many junctions must be connected in series. The resulting voltages still typically fall below the level a transistor requires, which makes ultra-low-voltage step-up conversion an essential companion to any biothermal generator.

The largest and most stable gradients are available at the skin, where wearable and shallowly implanted thermoelectric generators can supply microwatts to a few milliwatts per square centimeter depending on activity and ambient conditions. Deep within the body the temperature is nearly uniform, so fully internal thermoelectric harvesting is limited; the most practical biothermal devices therefore bridge the body and the external environment rather than relying on an internal gradient alone.

Thermoelectric Materials and Heat Management

Bismuth telluride and its alloys remain the standard thermoelectric materials near body temperature because their figure of merit peaks close to room temperature. Thin-film and flexible thermoelectric constructions allow the generator to conform to curved anatomy and to maintain intimate thermal contact with tissue. The conversion efficiency available from a one- to two-degree gradient is intrinsically low, on the order of a fraction of a percent, so designers focus less on efficiency than on maximizing heat flow through the device and minimizing parasitic thermal resistance at the interfaces.

Effective heat management dominates biothermal design. The skin and subcutaneous tissue present a high thermal resistance, and the air-side interface must reject heat efficiently or the cold side warms until the gradient collapses. Heat spreaders, finned surfaces on wearable units, and careful matching of the device thermal resistance to that of the tissue all improve sustained output. Because the body replenishes heat continuously, a well-designed biothermal generator can operate indefinitely, making it attractive for devices that must run for the lifetime of the patient.

Cardiac and Respiratory Motion

The heart is an especially attractive mechanical source because it contracts reliably roughly once per second for the entire life of the patient and performs significant mechanical work with each beat. Harvesters attached to the epicardial surface or coupled to the motion of the heart wall can capture energy from this deformation and acceleration. Piezoelectric ribbons and flexible generators bonded to the beating heart have demonstrated, in animal studies, output sufficient in principle to power a pacemaker, raising the prospect of a self-sustaining cardiac device that never requires battery replacement.

Respiration provides a slower but also continuous mechanical source. The rise and fall of the diaphragm and the expansion of the chest wall and lungs produce cyclic strain that can be harvested by devices coupled to these structures. Because the heart and lungs move whether the patient is awake or asleep, active or at rest, cardiac and respiratory harvesting offer a dependable baseline of energy that is independent of voluntary activity, an important advantage for life-critical implants.

Body Motion and Locomotion

Gross body motion during walking and other activity dissipates far more energy than cardiac or respiratory motion, though it is intermittent and depends on the patient. Inertial harvesters use a suspended proof mass that moves relative to the device housing as the body accelerates, driving a piezoelectric or electromagnetic transducer. Such devices are well suited to limb-mounted or subcutaneous placement where they experience the accelerations of gait. Joint motion at the knee and hip dissipates the most power of all, and harvesters that couple to these joints can in principle generate watts, though capturing this energy without impeding natural movement is difficult.

Because locomotion is irregular, harvesters that depend on it must be paired with energy storage that buffers active periods against periods of rest. The intermittent and patient-dependent character of body-motion harvesting makes it better suited to devices that tolerate variable power, such as data loggers and intermittently transmitting sensors, than to implants that demand a strictly continuous supply.

Piezoelectric, Triboelectric, and Electromagnetic Transducers

Three transduction principles dominate biomechanical harvesting. Piezoelectric transducers generate charge when strained and suit the small, cyclic deformations of organs and tissue; flexible piezoelectric polymers and thin-film ceramics conform well to soft anatomy. Triboelectric generators produce charge through contact electrification and separation of dissimilar materials and can deliver high voltages from low-frequency motion, making them attractive for harvesting the slow movements typical of the body, though their charge per cycle is modest. Electromagnetic transducers, using a moving magnet and coil, excel at larger displacements and lower frequencies and suit inertial harvesting of bulk body motion.

Each principle presents distinct trade-offs for implantation. Piezoelectric and triboelectric devices can be made thin and flexible but often produce high-impedance, high-voltage outputs that require careful interface electronics. Electromagnetic devices tend to be bulkier because they require magnets and coils, but they produce lower-impedance outputs that are easier to manage. Hybrid devices that combine principles can broaden the range of motion frequencies and amplitudes from which energy is captured, improving total harvest under the variable mechanical conditions of the body.

Enzymatic and Abiotic Glucose Fuel Cells

A glucose biofuel cell oxidizes glucose at its anode and reduces oxygen at its cathode, harvesting the electrons that flow between them. Enzymatic cells use immobilized enzymes such as glucose oxidase or glucose dehydrogenase at the anode and oxygen-reducing enzymes at the cathode. These enzymes are highly selective and operate at body temperature and neutral pH, which allows the cell to function while bathed directly in biological fluid without a separating membrane. Their drawback is limited operational lifetime, because enzymes denature and lose activity over weeks to months, which presently restricts purely enzymatic cells to shorter-term applications.

Abiotic glucose fuel cells replace enzymes with noble-metal or carbon-based catalysts that are far more stable but less selective, requiring more careful electrode design to favor glucose oxidation over competing reactions. Abiotic cells trade lower peak power for greatly extended stability, an attractive balance for permanent implants. Both approaches deliver power densities in the microwatt-per-square-centimeter range under physiological glucose concentrations, sufficient for low-power sensors and, in larger-area configurations, potentially for stimulators.

Mass Transport, Power Density, and Stability

The output of an implanted biofuel cell is governed less by the abundance of fuel than by the rate at which glucose and oxygen reach the electrodes. Oxygen is the limiting reactant in many body fluids because its dissolved concentration is far lower than that of glucose, so cathode design and oxygen transport frequently set the achievable power. Electrodes with high surface area, such as porous carbon and nanostructured materials, increase the reaction interface and improve current. Because the cell draws fuel from the surrounding fluid, it must not deplete local glucose or oxygen to levels that disturb nearby tissue.

Long-term stability remains the central obstacle to clinical biofuel cells. Enzyme degradation, biofouling of the electrodes by adsorbed proteins and cells, and the foreign-body response that encapsulates the implant in fibrous tissue all reduce output over time. Protective coatings, anti-fouling surface chemistries, and self-regenerating or replaceable enzyme systems are active areas of research aimed at extending useful lifetime from months toward the years required for permanent implantation.

Inductive Coupling

Inductive power transfer uses a transmitting coil outside the body that is magnetically coupled to a receiving coil within the implant. An alternating current in the external coil induces a voltage in the implant coil, which is rectified and regulated to power the device and to recharge an internal battery. This technique already powers cochlear implants and recharges many implantable neurostimulators, and transcutaneous energy transfer has been pursued for ventricular assist devices and total artificial hearts as a way to eliminate the infection-prone percutaneous driveline, though such systems remain largely investigational and most circulatory-support devices are still powered through a driveline. Operating frequencies typically fall in the low-megahertz range, balancing tissue absorption against coupling efficiency.

Inductive systems can deliver from milliwatts to watts depending on coil size, separation, and alignment, which is far beyond what internal harvesting achieves. Their principal limitations are sensitivity to coil alignment and separation distance, the need for the patient to wear or position the external transmitter, and the requirement to keep tissue heating from absorbed field energy within safe limits. Resonant coupling, in which both coils are tuned to the same frequency, extends the practical range and tolerance to misalignment, improving the convenience of recharging.

Ultrasonic Power Transfer

Ultrasonic power transfer carries energy through tissue as acoustic pressure waves rather than electromagnetic fields. An external transducer emits ultrasound that an implanted piezoelectric receiver converts back into electricity. Ultrasound propagates efficiently through soft tissue and is not subject to the same absorption and shielding effects that attenuate radio-frequency fields, which makes it especially attractive for deep implants where inductive coupling weakens. Diagnostic ultrasound already demonstrates that acoustic energy can be focused safely deep within the body.

Because ultrasound can be focused tightly and its safe exposure limits are well established, ultrasonic links can power millimeter-scale implants placed deep in tissue, enabling very small, leadless devices for neural and other applications. The trade-offs include sensitivity to acoustic path and alignment, the impedance mismatch where waves cross from soft tissue into bone or gas-filled organs, and the need to keep acoustic intensity within limits that prevent tissue heating and cavitation. Ultrasonic and inductive methods are complementary, with the acoustic approach favored for deep, small targets and the inductive approach for larger, shallower devices.

Radio-Frequency and Midfield Powering

Far-field and midfield radio-frequency powering use higher-frequency electromagnetic energy that can reach deeper or smaller implants than conventional near-field inductive coils. Midfield techniques shape the field at the body surface so that it converges toward a small, deeply located receiver, allowing power delivery to millimeter-scale devices in locations such as the heart or deep nervous tissue. These methods trade lower delivered power for greater reach and miniaturization, and they must respect strict limits on the rate at which tissue absorbs electromagnetic energy. They are best suited to ultra-low-power implants where the very small size of the receiver outweighs the limited power available.

Hermetic Encapsulation and Biocompatible Materials

Electronics implanted in the body must be protected from the corrosive, saline, enzyme-rich environment that would otherwise destroy them within days. Established implants use hermetic enclosures of titanium or biocompatible ceramic that exclude moisture and ions while allowing electrical feedthroughs for sensing and stimulation. For harvesters that must exchange heat, motion, or chemical reactants with the body, the package becomes more complex, since it must couple the relevant energy across the barrier while still excluding fluid from the sensitive electronics.

Materials in direct tissue contact must be biocompatible and chemically stable. Titanium, platinum, iridium oxide, certain ceramics, and selected polymers such as medical-grade silicone and parylene are well established for chronic implantation. Flexible and conformal harvesters increasingly rely on encapsulation strategies that combine thin barrier coatings with biocompatible elastomers to protect bendable electronics while maintaining the mechanical compliance needed to avoid irritating soft tissue. The encapsulation must endure the body for the full intended lifetime, since a single breach can cause device failure and an adverse tissue reaction.

Ultra-Low-Power Conversion and Energy Storage

Harvested power within the body is typically delivered at inconvenient voltages and currents: thermoelectric generators produce tens of millivolts, piezoelectric and triboelectric devices produce high-voltage pulses, and biofuel cells produce low voltages at high source impedance. Power-management integrated circuits condition these outputs into a regulated supply. Ultra-low-voltage boost converters with cold-start capability can begin operating from inputs of a few tens of millivolts, a necessity for thermoelectric harvesting. Rectifiers and charge-management circuits capture the pulsed output of mechanical harvesters efficiently, and maximum-power-point tracking matches the converter to the source to extract the most energy.

Because nearly all physiological sources are weak, intermittent, or both, energy storage is essential to buffer generation against demand. Thin-film microbatteries and supercapacitors store harvested energy and deliver the brief, higher-power bursts that radios and stimulators require. Power management must also gracefully handle the times when the harvester cannot meet demand, drawing on stored energy and reducing the duty cycle of noncritical functions. In many practical systems the harvester does not power the device directly but instead trickle-charges a buffer that the device draws from, decoupling the variability of harvesting from the needs of the load.

The Foreign-Body Response and Long-Term Stability

Any object implanted in the body provokes a foreign-body response, beginning with the adsorption of proteins onto the surface and progressing to inflammation and the formation of a fibrous capsule that walls off the device. This capsule degrades harvesters that depend on exchange with tissue: it adds thermal resistance that reduces thermoelectric output, it stiffens and damps mechanical harvesters, and it impedes the transport of glucose and oxygen to biofuel-cell electrodes. Surface chemistries that resist protein adsorption, anti-inflammatory coatings, and geometries that minimize tissue irritation all help mitigate encapsulation and preserve output over time.

Long-term stability must be demonstrated over the years or decades an implant is expected to function. Materials must not corrode, leach toxic products, or fatigue under millions of mechanical cycles. A cardiac harvester, for instance, must survive on the order of hundreds of millions of cycles over a decade without mechanical failure or loss of output. Accelerated aging, fatigue testing, and chronic animal studies are used to establish that a device will endure, since failure of an implanted device carries far graver consequences than failure of a consumer product.

Thermal, Electrical, and Mechanical Safety

Safety constraints are non-negotiable. Heating of surrounding tissue must remain within strict limits, which bounds both the power dissipated by the electronics and the energy absorbed during wireless power transfer. Electrical safety requires that leakage and fault currents never reach levels that could stimulate excitable tissue or cause harm, and that the device fail safely if any component breaks down. Mechanical safety demands that the device not erode tissue, migrate from its intended location, or fracture in a way that could injure surrounding structures.

Electromagnetic compatibility is a further concern, since an implant must tolerate external interference and the strong fields of medical imaging without malfunctioning or heating. Regulatory approval of any implantable device requires comprehensive biocompatibility testing under recognized international standards, electrical safety verification, and clinical evidence of safety and efficacy. These requirements lengthen development and raise the bar for any harvesting technology, which helps explain why transcutaneous powering, already proven safe in clinical use, has been adopted far more widely than internal harvesting techniques that remain largely in research.

Cardiac Devices: Pacemakers and Defibrillators

The pacemaker is the canonical target for in-vivo harvesting because its power demand is low, its placement is intimate with a strong mechanical source, and its battery determines the device lifetime and the need for replacement surgery. Harvesters coupled to the motion of the beating heart have shown, in preclinical work, the ability to generate power on the order of what a pacemaker consumes, pointing toward a future self-powered device. Leadless pacemakers placed directly inside the heart chamber are an especially natural fit for both cardiac-motion harvesting and ultrasonic or midfield wireless powering, because their tiny size benefits from the miniaturization those methods allow.

Implantable defibrillators present a harder challenge because, although their average power is modest, they must deliver high-energy shocks on demand, which requires substantial stored energy. Harvesting can extend battery life by supplying the continuous background load of sensing and pacing, reducing the rate at which the battery is consumed and lengthening the interval between replacements, even where it cannot supply the shock energy directly.

Neural Implants and Biosensors

Neurostimulators for deep-brain stimulation, spinal cord stimulation, and peripheral nerve interfaces span a wide range of power demands. Many are already rechargeable by inductive transcutaneous power, and miniature neural interfaces are leading adopters of ultrasonic and midfield powering because those methods can reach small, deeply placed devices. Reducing or eliminating the implanted battery shrinks these devices and lessens the surgical burden of replacement, which is especially valuable for interfaces in delicate locations.

Implantable biosensors that monitor glucose, pressure, oxygenation, or biochemical markers are often the best match for low-power harvesting because they transmit intermittently and tolerate variable supply. A continuous glucose sensor powered by a glucose biofuel cell is a conceptually elegant pairing, since the very analyte being measured can also fuel the device. Pressure sensors for monitoring blood vessels, the bladder, or the eye, and a broad class of ingestible and injectable sensors, similarly benefit from harvesting or wireless powering that frees them from a bulky battery and enables truly miniature, long-lived implants.